Zhu S - Search Results

1

BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo.

Yang Q, To KKW, Hu G, Fu K, Yang C, Zhu S, Pan C, Wang F, Luo K, Fu L. Yang Q, et al. Among authors: zhu s. Cell Commun Signal. 2024 Jun 13;22(1):325. doi: 10.1186/s12964-024-01698-4. Cell Commun Signal. 2024. PMID: 38872211 Free PMC article.

2

The prospect of combination therapies with the third-generation EGFR-TKIs to overcome the resistance in NSCLC.

Li S, Zhu S, Wei H, Zhu P, Jiao Y, Yi M, Gong J, Zheng K, Zhang L. Li S, et al. Among authors: zhu s, zhu p. Biomed Pharmacother. 2022 Dec;156:113959. doi: 10.1016/j.biopha.2022.113959. Epub 2022 Nov 5. Biomed Pharmacother. 2022. PMID: 36411663 Free article. Review.

3

Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers.

Yi M, Niu M, Zhang J, Li S, Zhu S, Yan Y, Li N, Zhou P, Chu Q, Wu K. Yi M, et al. Among authors: zhu s. J Hematol Oncol. 2021 Sep 15;14(1):146. doi: 10.1186/s13045-021-01155-6. J Hematol Oncol. 2021. PMID: 34526097 Free PMC article.

4

Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer.

Yi M, Wu Y, Niu M, Zhu S, Zhang J, Yan Y, Zhou P, Dai Z, Wu K. Yi M, et al. Among authors: zhu s. J Immunother Cancer. 2022 Dec;10(12):e005543. doi: 10.1136/jitc-2022-005543. J Immunother Cancer. 2022. PMID: 36460337 Free PMC article.

5

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors.

Yi M, Niu M, Wu Y, Ge H, Jiao D, Zhu S, Zhang J, Yan Y, Zhou P, Chu Q, Wu K. Yi M, et al. Among authors: zhu s. J Hematol Oncol. 2022 Oct 8;15(1):142. doi: 10.1186/s13045-022-01363-8. J Hematol Oncol. 2022. PMID: 36209176 Free PMC article.

6

The role of gut microbiota and metabolites in cancer chemotherapy.

Li S, Zhu S, Yu J. Li S, et al. Among authors: zhu s. J Adv Res. 2024 Oct;64:223-235. doi: 10.1016/j.jare.2023.11.027. Epub 2023 Nov 26. J Adv Res. 2024. PMID: 38013112 Free PMC article. Review.

7

Roles of Microvesicles in Tumor Progression and Clinical Applications.

Zhu S, Li S, Yi M, Li N, Wu K. Zhu S, et al. Int J Nanomedicine. 2021 Oct 18;16:7071-7090. doi: 10.2147/IJN.S325448. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34703228 Free PMC article. Review.

8

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions.

Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K. Yi M, et al. Among authors: zhu s. Mol Cancer. 2022 Jan 21;21(1):28. doi: 10.1186/s12943-021-01489-2. Mol Cancer. 2022. PMID: 35062949 Free PMC article. Review.

9

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer.

Zhang H, Zhu S, Zhou H, Li R, Xia X, Xiong H. Zhang H, et al. Among authors: zhu s. Front Oncol. 2023 Jan 16;13:1098357. doi: 10.3389/fonc.2023.1098357. eCollection 2023. Front Oncol. 2023. PMID: 36726381 Free PMC article.

10

Focal adhesion kinase: from biological functions to therapeutic strategies.

Tan X, Yan Y, Song B, Zhu S, Mei Q, Wu K. Tan X, et al. Among authors: zhu s. Exp Hematol Oncol. 2023 Sep 25;12(1):83. doi: 10.1186/s40164-023-00446-7. Exp Hematol Oncol. 2023. PMID: 37749625 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,828 results

Search Page

Filters